Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
127,672,444
-
Total 13F shares
-
69,511,931
-
Share change
-
+4,852,326
-
Total reported value
-
$2,291,947,609
-
Put/Call ratio
-
114%
-
Price per share
-
$32.96
-
Number of holders
-
174
-
Value change
-
-$95,194,645
-
Number of buys
-
103
-
Number of sells
-
103
Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock (APLS) as of Q3 2021
As of 30 Sep 2021,
Apellis Pharmaceuticals, Inc. - Common Stock (APLS) was held by
174 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,511,931 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, JENNISON ASSOCIATES LLC, CITADEL ADVISORS LLC, VICTORY CAPITAL MANAGEMENT INC, and FMR LLC.
This page lists
174
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.